These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38048572

  • 1. CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.
    Adams RC, Carter-Cusack D, Llanes GT, Hunter CR, Vinnakota JM, Ruitenberg MJ, Vukovic J, Bertolino P, Chand KK, Wixey JA, Nayler SP, Hill GR, Furlan SN, Zeiser R, MacDonald KPA.
    Blood; 2024 Mar 07; 143(10):912-929. PubMed ID: 38048572
    [Abstract] [Full Text] [Related]

  • 2. Donor bone marrow-derived macrophage MHC II drives neuroinflammation and altered behavior during chronic GVHD in mice.
    Adams RC, Carter-Cusack D, Shaikh SN, Llanes GT, Johnston RL, Quaife-Ryan G, Boyle G, Koufariotis LT, Möller A, Blazar BR, Vukovic J, MacDonald KPA.
    Blood; 2022 Mar 03; 139(9):1389-1408. PubMed ID: 34570880
    [Abstract] [Full Text] [Related]

  • 3. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice.
    Shaikh SN, Willis EF, Dierich M, Xu Y, Stuart SJS, Gobe GC, Bashaw AA, Rawashdeh O, Kim SJ, Vukovic J.
    J Neuroinflammation; 2023 Dec 15; 20(1):300. PubMed ID: 38102698
    [Abstract] [Full Text] [Related]

  • 4. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.
    Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, Lor M, Raffelt NC, Koyama M, Leveque L, Le Texier L, Melino M, Markey KA, Varelias A, Engwerda C, Serody JS, Janela B, Ginhoux F, Clouston AD, Blazar BR, Hill GR, MacDonald KP.
    J Clin Invest; 2014 Oct 15; 124(10):4266-80. PubMed ID: 25157821
    [Abstract] [Full Text] [Related]

  • 5. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2006 Oct 15; 6(6):1-82. PubMed ID: 23074497
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
    Müller AMS, Min D, Wernig G, Levy RB, Perez VL, Herretes S, Florek M, Burnett C, Weinberg K, Shizuru JA.
    Biol Blood Marrow Transplant; 2019 Dec 15; 25(12):2338-2349. PubMed ID: 31415899
    [Abstract] [Full Text] [Related]

  • 8. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA, Cutler A, Doree C, Brunskill SJ, Stanworth SJ, Navarrete C, Girdlestone J.
    Cochrane Database Syst Rev; 2019 Jan 30; 1(1):CD009768. PubMed ID: 30697701
    [Abstract] [Full Text] [Related]

  • 9. Ex Vivo Generated Human Cord Blood Myeloid-Derived Suppressor Cells Attenuate Murine Chronic Graft-versus-Host Diseases.
    Lim JY, Ryu DB, Park MY, Lee SE, Park G, Kim TG, Min CK.
    Biol Blood Marrow Transplant; 2018 Dec 30; 24(12):2381-2396. PubMed ID: 30006304
    [Abstract] [Full Text] [Related]

  • 10. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
    Wu T, Young JS, Johnston H, Ni X, Deng R, Racine J, Wang M, Wang A, Todorov I, Wang J, Zeng D.
    J Immunol; 2013 Jul 01; 191(1):488-99. PubMed ID: 23709681
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.
    Blood; 2003 Mar 01; 101(5):2033-42. PubMed ID: 12393418
    [Abstract] [Full Text] [Related]

  • 13. CCL1 blockade alleviates human mesenchymal stem cell (hMSC)-induced pulmonary fibrosis in a murine sclerodermatous graft-versus-host disease (Scl-GVHD) model.
    Lim JY, Ryu DB, Kim TW, Lee SE, Park G, Yoon HK, Min CK.
    Stem Cell Res Ther; 2020 Jun 26; 11(1):254. PubMed ID: 32586381
    [Abstract] [Full Text] [Related]

  • 14. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
    Drobyski WR, Majewski D.
    Blood; 1996 Jun 15; 87(12):5355-69. PubMed ID: 8652851
    [Abstract] [Full Text] [Related]

  • 15. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE, McNiff JM, Jain D, Blazar BR, Shlomchik WD, Shlomchik MJ.
    Blood; 2005 Mar 01; 105(5):2227-34. PubMed ID: 15522961
    [Abstract] [Full Text] [Related]

  • 16. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2003 Apr 01; 9(4):243-56. PubMed ID: 12720217
    [Abstract] [Full Text] [Related]

  • 17. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
    Iliopoulou BP, Hsu K, Pérez-Cruz M, Tang SW, Pang WW, Erkers T, Kambham N, Freeman GJ, Dekruyff RH, Meyer EH.
    Blood Adv; 2019 Nov 12; 3(21):3419-3431. PubMed ID: 31714958
    [Abstract] [Full Text] [Related]

  • 18. Alemtuzumab, Dual Graft-versus-Host Disease Prophylaxis, and Lower CD3+ T Cell Doses Equalize Rates of Acute and Chronic Graft-versus-Host Disease in Pediatric Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation with Matched Unrelated Donor Peripheral Blood Stem Cells or Bone Marrow Grafts.
    Lum SH, James B, Ottaviano G, Ewins AM, Patrick K, Ali S, Carpenter B, Silva J, Tewari S, Furness C, Thomas A, Shenton G, Bonney D, Moppett J, Hambleton S, Gennery AR, Amrolia P, Gibson B, Hough R, Rao K, Slatter M, Wynn R.
    Transplant Cell Ther; 2024 Mar 12; 30(3):314.e1-314.e12. PubMed ID: 38103787
    [Abstract] [Full Text] [Related]

  • 19. Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice.
    Radojcic V, Paz K, Chung J, Du J, Perkey ET, Flynn R, Ivcevic S, Zaiken M, Friedman A, Yan M, Pletneva MA, Sarantopoulos S, Siebel CW, Blazar BR, Maillard I.
    Blood; 2018 Nov 15; 132(20):2188-2200. PubMed ID: 30181175
    [Abstract] [Full Text] [Related]

  • 20. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.
    Wu Y, Tang CA, Mealer C, Bastian D, Hanief Sofi M, Tian L, Schutt S, Choi HJ, Ticer T, Zhang M, Sui X, Huang L, Mellor AL, Hu CA, Yu XZ.
    Cell Mol Immunol; 2021 Mar 15; 18(3):632-643. PubMed ID: 33500563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.